Chromatin structure, determined in part by DNA methylation, is established during differentiation and prevents expression of genes unnecessary for the function of a given cell type. We reported that DNA methylation and chromatin structure contributes to lymphoidspecific ITGAL (CD11a) and PRF1 (perforin) expression. We used bisulfite sequencing to compare methylation patterns in the ITGAL promoter and 5' flanking region of T cells and fibroblasts, and in the PRF1 promoter and upstream enhancer of CD4+ and CD8+ T cells with fibroblasts. The effects of methylation on promoter function were tested using regional methylation of reporter constructs, and confirmed by DNA methyltransferase inhibition. The relationship between DNA methylation and chromatin structure was analyzed by DNaseI hypersensitivity. Herein we described the methods and results in greater detail.
INTRODUCTION
DNA methylation in vertebrates refers to the methylation of deoxycytosine (dC) bases in CG pairs, and is associated with gene silencing. DNA methylation is essential for mammalian development (1) , and contributes to gene silencing in differentiation, genomic imprinting, X chromosome inactivation, and suppression of parasitic DNA (2) . Acquired changes in DNA methylation patterns have been implicated in the changes in gene expression that contribute to carcinogenesis, autoimmunity and aging (3) . The importance of DNA methylation in normal and pathologic cellular processes has stimulated a growing interest in how DNA methylation suppresses gene expression, and in examining how changes in methylation patterns affect gene expression.
DNA methylation can inhibit gene expression by several mechanisms. The methylation of promoter sequences inhibits the binding of some transcription factors. Members of the methylcytosine binding protein family, such as methyl-CpGbinding protein 2 (MeCP2), specifically bind methylated DNA, blocking access of other factors required for gene transcription. More importantly, though, the binding of methylcytosine binding proteins to methylated DNA recruits chromatin inactivation complexes containing co-repressors and histone deacetylases, leading to a change in the chromatin structure from an open, transcriptionally permissive form to a more compact, inactive form, inaccessible to the transcription machinery (1) . In general, methylation of sequences in or near regulatory elements have suppressive effects on gene expression, while methylation of coding sequences has little to no effect (4).
Several strategies have been devised for the quantitative assessment of total genomic deoxycytosine (dC) and deoxymethylcytosine content, as well as the methylation status of specific sequences. These are the subject of a recent review (5) . At present, the most precise and generally applicable techniques for sequence-specific methylation analysis rely on bisulfite modification of DNA. Treating DNA with bisulfite deaminates cytosine bases to form uracil, but does not affect methylcytosine. Thus, PCR amplification and sequencing of bisulfite treated DNA allows precise quantitation of the methylation status of any desired CG pair (6) . This approach, coupled with regional methylation of dC bases in promoter reporter constructs and DNaseI hypersensitivity analysis of chromatin structure in the region, provides information regarding both the presence and functional significance of the methylation patterns. Further confirmation may be obtained by demethylating DNA with the irreversible DNA methyltransferase inhibitor 5-azacytidine (5-azaC), then comparing effects on gene expression and methylation patterns.
In this report we describe the methods utilized to compare the methylation patterns of the ITGAL (CD11a) promoter in T cells and fibroblasts, and of the PRF1 (perforin) promoters in T cells, an NK cell line and in fibroblasts, and how cassette or "patch" methylation may be used to test the effects of regional methylation on ITGAL and PRF1 promoter function. We also describe the use of DNaseI hypersensitivity assays to probe the chromatin structure around the same genes in representative cells with differential CD11a and perforin expression, and the use of DNA methyltransferase inhibition to confirm transcriptionally relevant changes in DNA methylation patterns.
MATERIALS AND METHODS

Cell and cell lines
T cells were isolated from the peripheral venous blood of healthy donors by density gradient centrifugation followed by e-rosetting. CD4+ and CD8+ subsets were isolated using Miltenyi beads and protocols provided by the manufacturer (Miltenyi, Auburn, CA). Purity was checked by flow cytometry and was typically > 94% CD4+ or CD8+. Where indicated the T cells were stimulated for 24 hours with 1 µg/ml phytohemagglutinin (PHA), then treated with 5-azaC or 2-deoxy-5-azaC (Sigma, St. Louis, MO) for an additional 72 hours as described (7, 8) . Dermal fibroblasts from a healthy donor were donated by Dr. Samir Hanash, and synovial fibroblasts from a patient with osteoarthritis were provided by Dr. C. William Castor. YT cells, a perforin-expressing NK cell line, were provided by Dr. Y. Tagaya (National Cancer Institute, Bethesda, MD) and cultured as described (7) . Jurkat cells (E6-1), a generous gift from Dr. Arthur Weiss, were cultured as previously described (9) . SAM-19 cells were donated by Dr. Mathias Lichtenheld and cultured as described (7) .
Bisulfite genomic sequencing 1-5 µg of purified DNA was treated with sodium bisulfite (10) , then the desired sequences were amplified in sequential fragments using nested PCR. The primers were designed to account for the conversion of dC to dU by the bisulfite and avoid CG pairs, and EcoRI sites were added to the forward primers, and XbaI to the reverse, to facilitate cloning.
Patch methylation and transient transfections
A 1.9kb XhoI fragment containing the human ITGAL promoter and 5' flanking region or a 1459-bp fragment encoding the perforin promoter and proximal enhancer were cloned into the luciferase-containing reporter vector pGL3-Basic (Promega). Appropriate restriction sites were engineered into the fragments to permit excision of the relevant regions using the QuikChange site-directed mutagenesis kit (Stratagene) and effects on promoter function excluded by transient transfection (7, 10) . The regions of interest were then excised using the appropriate restriction endonucleases, gel purified, and methylated with SssI and S-adenosylmethionine (both from New England Biolabs, Beverly, MA) using instructions provided by the manufacturer. The methylated fragments were then ligated back into the expression constructs and methylation confirmed by digestion with appropriate methylation sensitive restriction endonucleases. Controls included mock methylated constructs similarly generated but omitting the SssI (7, 10) . The methylated or mock methylated pGL3-ITGAL constructs were then transfected into Jurkat cells, and the pGL3-PRF1 constructs were transfected into SAM-19 cells, using electroporation and previously described protocols (7, 10) . β-galactosidase or Renilla luciferase expression constructs (pRL-CMV; Promega) were used as transfection controls. Twenty-four hours later the cells were washed twice with PBS, suspended in 400 µl reporter lysis buffer (Promega), and lysed by freeze/thaw. Insoluble material was removed by centrifugation and luciferase or β-galactosidase measured. Briefly, β-galactosidase determinations were performed using the Galacto-Light system as per the manufacturer's protocol (Tropix, Bedford, MA) while luciferase assays were performed using the Dual-Luciferase Reporter Assay Kit (Promega) and instructions provided by the manufacturer, measuring fluorescence with a Turner Designs (Sunnyvale, CA) luminometer.
DNase1 hypersensitivity
DNase1 hypersensitivity assays were performed as described (7, 11) . Briefly, isolated nuclei were treated with 0, 40, 80, or 160 U/ml DNaseI (Worthington, Lakewood, NJ) at room temperature for 3 minutes, then the reaction was stopped with 20 mM EGTA/1% SDS and DNA isolated, digested with EcoRI for PRF1 or SacI for ITGAL, fragments fractionated by agarose gel electrophoresis, then transferred to nylon filters. The filters were hybridized with a 32 P-labelled 277 bp fragment excised with EcoRI and XbaI (-1410 to -1133 relative to the transcription start site) from a 1459 bp fragment encoding the perforin gene promoter and 5' flanking region, or with a fragment spanning bp +1060 to +1264 (relative to the transcription start site) of the ITGAL gene, amplified by PCR (7, 11) .
RESULTS
Methylation status of the ITGAL and PRF1 promoters and 5' flanking regions in expressing and nonexpressing cells ITGAL promoter methylation patterns were compared in fibroblasts and T lymphocytes as representative nonpermissive and permissive cell types. Figure 1A shows the ITGAL promoter numbered relative to the transcription start site (12) . There are 22 potentially methylatable CG pairs between the 5' end of the fragment and the transcription start site, and 5 following. For reference, a region containing Alu elements and the transcriptionally relevant PU.1 and Sp1 sites are also shown (12) . DNA was isolated from synovial or dermal fibroblasts, treated with bisulfite, then the ITGAL promoter and 5' flanking region were amplified, cloned, and 5 fragments sequenced from each region. Figure 1B shows the methylation status of each CG pair averaged over the 10 fragments from the 2 fibroblast types. Nearly all CG pairs are relatively heavily methylated (> 50%) in the DNA from both lines. Figure 1C shows the methylation pattern from the same region in T lymphocytes isolated from 4 to 6 healthy donors. The transcribed region is completely demethylated in all fragments from the 4 healthy subjects examined, while most of the sequence 5' to the transcription start site was partially methylated in all controls. Of note is the region containing Alu elements, identified by the bar, which is more heavily methylated in all subjects, consistent with reports that repetitive DNA sequences are usually heavily methylated (13). 
Perforin promoter methylation in T cells, NK cells and fibroblasts
A similar approach was used to compare PRF1 methylation patterns in YT cells, a human NK cell line that constitutively expresses perforin, and fibroblasts, which do not. Key elements of the human PRF1 promoter and 5' flanking region are shown in Figure 2A . The first 1300 bp 5' to the transcription initiation site contains 29 potentially methylatable CG pairs. The first 55 bp 5' to the start site contains a core promoter with a GC box. A series of repetitive elements is located between -396 and -83, and a region containing enhancer elements is located between -1136 and -983 (14, 15) . Relevant transcription factor binding sites are also shown. The methylation pattern of this region was then compared in YT cells and fibroblasts using the same techniques applied to the ITGAL promoter. Figure 2B shows the average of the 10 determinations for each CG pair in the PRF1 promoter of the two fibroblast lines, and Figure 2C shows the methylation status of each CG pair in four to five fragments from the YT cells. The region is largely methylated in fibroblasts. In contrast, only a single methylated dC base was detected in perforinexpressing YT cells.
These results were then confirmed in primary CD4+ and CD8+ T cells. In cytotoxic CD8+ T cells, perforin expression is regulated by signals from the IL-2 receptor activating STAT5, which then binds the enhancer region shown in Figure 2A (15) . However, primary CD4+ T cells do not normally express the gene (7) . Figure 2D shows the methylation pattern of the same region in CD4+ T cells from 6-7 normal individuals. The region from -1326 through-650 is relatively heavily methylated, while the more proximal CG pairs become progressively less methylated the closer they are to the transcription start site, with most of the methylated residues in the proximal sequences located in the region containing repetitive elements ( Fig. 2A) . Figure 2E shows the average methylation status of the same region in CD8+ T cells isolated from 4-5 healthy subjects. Overall, the entire region tends to be less methylated in CD8+ T cells compared to CD4+ cells (mean fraction methylated 0.23 vs 0.48, CD8 vs CD4, p < 0.001 by paired t-test). The region from -1326 to -1000 is less methylated than the corresponding region in the CD4+ T cells (0.89 vs 0.52 for the analyzed region, CD4 vs CD8, p = 0.003). The region from -1000 to -599, flanking the enhancer elements (Fig. 3A) , is also significantly (p = 0.001) less methylated in CD8+ T cells relative to CD4+ T cells (mean fraction methylated 0.41 vs 0.71), although there is one exception at -720. The region from -457 to the transcription start site was also less methylated in the CD8+ T cells (0.21 vs 0.07, CD4 vs CD8, p < 0.001). 
Effects of methylation on ITGAL and PRF1 promoter and enhancer function
The relative importance of sequence specific methylation can be determined using regional or "patch" methylation. The approach used by our group is to excise the region of interest from a reporter construct, methylate the fragment in vitro with SssI and S-adenosylmethionine, ligate the methylated fragment back into the construct, and compare expression of the methylated construct and controls in transfected cells (7, 10) .
The effect of methylation of the ITGAL promoter 5' flanking region was determined by first inserting an NdeI site into the ITGAL promoter at bp -382. The regions from -1818 to -382 or from -382 to +79 were then excised, methylated in vitro, ligated back into the construct, and transfected into Jurkat cells. Figure  3A shows that methylation of the region from the 5' end of the cloned promoter fragment to -382 partially suppresses promoter activity relative to controls, consistent with reports that methylation can suppress promoter function from a distance (1). Methylation of the region containing the active promoter (-362 to +79) suppressed to a greater degree. These studies suggest that ITGAL promoter activity is methylation sensitive. Similar studies examined the functional effects of methylation on the PRF1 gene. These studies used a previously described 1459-bp fragment containing the perforin promoter and upstream enhancer driving a firefly luciferase reporter gene (15) . An NdeI site was inserted at -290, and a StuI site at -14. The region from -1410 to -290 was then excised with EcoRI and NdeI, and the region from -1410 to -14 with EcoRI and StuI. The fragments were purified, similarly methylated with Sss1 and Sadenosylmethionine, ligated back into their respective reporter constructs, purified, and transfected into SAM-19 cells. Methylation of both regions inhibited promoter function, with methylation of -1410 to -14 giving slightly greater suppression (Fig. 3B ). This suggests that hypomethylation of the core promoter is insufficient to permit gene expression when the more 5' sequences are methylated. Figure 3B also shows that methylation of the promoter 5' flanking sequence (-979 to -527) decreased promoter function by ~70%. In contrast, methylating the distal 5' region (-1410 to -979) only decreased function by ~10%. This suggests that the methylation status of the region linking the promoter and enhancer, hypomethylated in CD8+ relative to CD4+ T cells, is important in PRF1 gene expression.
DNA demethylation and gene activation with DNA methylation inhibitors
The effects of DNA methylation on gene expression can be confirmed using the irreversible DNA methyltransferase inhibitor 5-azaC. 5-azaC is a cytosine analog that is incorporated into newly synthesized DNA, where it covalently binds DNA methyltransferases as they methylate the purine ring. This depletes cellular DNA methyltransferase pools and results in hypomethylation of the newly synthesized DNA strand. The cell retains a fully methylated parent strand. Following a second round of cell division, half the daughter cells will have symmetrically hypomethylated DNA, while the other half will have fully methylated DNA (16) . Thus, at most half the cells will be affected by one treatment, and effects are usually not seen until after 2 rounds of cell division (16) . Increased expression will be seen in those genes for which the cells express the necessary transcription factors, but which were suppressed by DNA methylation.
The effects of DNA methylation on PRF1 expression were confirmed by treating PHA stimulated CD4+ and CD8+ T cells with 5-azaC. Perforin expression increased in both cell types at the mRNA and protein levels (7) . Figures 4A and 4B show the methylation patterns of the distal 12 CG pairs in untreated and 5-azaC treated CD4+ T cells. The distal region is nearly completely methylated in the PHA stimulated CD4+ T cells, similar to that observed in unstimulated cells (Fig. 2) . 5-azaC demethylates the region between -600 and -900. Figures 4C and 4D show similar studies in untreated and 5-azaC treated CD8+ T cells. Again, there is a preferential demethylation of the region between -600 and -900. This is the same region differentially methylated between CD4+ and CD8+ T cells, and which when methylated suppresses promoter function. These results lend further support to the contention that methylation of this region suppresses perforin expression in T cells. Chromatin structure around the ITGAL gene was also compared in T cells and fibroblasts using DNaseI hypersensitivity. Transcriptionally inactive chromatin is typically characterized by a condensed, nonpermissive configuration, inaccessible to transcription factors. Initiation of transcription requires first a remodeling of the chromatin, such that promoter sequences become accessible to transcription factors. The open, permissive configuration also becomes accessible to the endonuclease DNaseI. Limited digestion of intact chromatin with DNaseI results in cleavage at these sites, typically in transcriptionally relevant regions. The sites may be mapped by secondary digestion with appropriate restriction endonucleases and traditional Southern blotting, using probes to the ends of restriction fragments (17) .
DNaseI hypersensitivity assays were used to determine if DNA hypomethylation correlated with a transcriptionally permissive chromatin configuration in the ITGAL gene. Nuclei were isolated from normal human T cells and fibroblasts then digested with increasing amount of DNaseI. DNA was then isolated, digested with SacI, and the fragments analyzed by southern blotting using a probe corresponding to bp +1060 to +1264 relative to the transcription start site. Figure 5A shows an approximately 3.2 kb fragment resulting from SacI digestion in both T cells and fibroblasts. Digestion with low concentrations of DNaseI causes the appearance of a prominent 1.4 kb band in T cells but not fibroblasts, while the highest concentration tested appears to cause some nonspecific digestion in both cell types. The cleavage site maps to the region just 5' to the transcription start site in T cells, and hypomethylated in T cells relative to fibroblasts (Fig. 5B) . This indicates that this hypomethylated region has a structure making the DNA more accessible to the enzyme in T cells, consistent with active chromatin.
Similarly, chromatin structure near the PRF1 promoter was compared in YT cells and fibroblasts, using limited DNaseI digestion. Nuclei were isolated and briefly digested with increasing amounts of DNaseI. DNA was then isolated, digested with EcoRI, and the fragments analyzed by Southern blotting, shown schematically in Figure 6A . A 2.65-kb EcoRI-EcoRI fragment is seen in both cells (Fig. 6B) . DNaseI digestion of YT cells releases 1.2-, 0.6-, 0.5-, and 0.4-kb fragments. In contrast, fibroblast DNA is resistant to DNaseI in this region. The DNaseI studies indicate that the perforin gene promoter/enhancer fragment was inaccessible to the enzyme in fibroblasts, but not in YT cells. Similar studies comparing DNaseI hypersensitive sites in primary CD4+ and CD8+ T cells demonstrated the same 1.2 kb fragment, mapping to the minimal promoter, in both cell types (Fig. 6C) . However, CD8+ cells also demonstrate a DNaseI hypersensitive site at 0.6 kb, indicating an open configuration near the enhancer region. This is just 5' to the region differentially methylated between CD4+ and CD8+ T cells (Fig. 3D) , where promoter function was suppressed by methylation of this region (Fig. 4B) . This is also adjacent to the STAT5 binding site regulating perforin expression (14) . Together this suggests that methylation of this region may contribute to a transcriptionally inactive configuration in CD4+ T cells. 
DISCUSSION
In this report we describe the use of bisulfite sequencing, regional methylation of promoters in reporter constructs, treatment of S-phase cells with 5-azaC to determine effects of DNA methylation on ITGAL and PRF1 gene expression, and the use of DNaseI hypersensitivity assays to correlate the methylation status of the regulatory regions with chromatin structure. Bisulfite sequencing revealed that the ITGAL promoter is heavily methylated in fibroblasts but not T cells, and that methylation of the core promoter suppressed promoter function. Further, hypomethylation of the ITGAL promoter and 5' flanking region correlated with the presence of a DNaseI hypersensitive site adjacent to the core promoter. These results indicate that ITGAL promoter methylation contributes to CD11a suppression in fibroblasts. The observation that hypomethylation correlates with a DNaseI hypersensitive site near the core promoter is consistent with evidence that DNA methylation contributes to gene silencing by attracting chromatin inactivation complexes promoting chromatin condensation into an inactive configuration (2, 4) . However, DNA hypomethylation does not always correlate with DNaseI hypersensitivity. Bisulfite sequencing of the PRF1 promoter and upstream enhancer region in YT cells, a transformed NK line, demonstrated nearly complete demethylation of the entire region. This is consistent with other reports that the DNA of transformed lines is generally hypomethylated, with the exception of certain CpG islands (18) . However, despite the overall hypomethylation, the DNaseI hypersensitive sites were nearly identical in YT cells and the relatively more methylated CD8+ T cells. Similarly, the ITGAL 5' flanking region was largely demethylated in T cells, but the only DNaseI hypersensitive site detected was adjacent to the core promoter. It is likely that other determinants of chromatin structure, such as histone acetylation and/or methylation, also contribute to the formation of the hypersensitive sites. These may be identified using chromatin immunoprecipitation approaches (19) .
One of the strengths of bisulfite sequencing is its general applicability to nearly any desired sequence. Further, methylation patterns can vary on a clonal basis (7) . By cloning and sequencing 5 or more fragment from each amplified region studied, an index of clonal variability can be obtained. Alternatively, the PCR products may be directly sequenced, giving a average of the methylation status of each CG pair. One limitation of bisulfite sequencing is that the technique requires PCR amplification, and GC rich sequences may be difficult to amplify. The use of improved Taq polymerases, such as Platinum Taq PCRx DNA polymerase from Invitrogen (Carlsbad, CA) may help in this situation. Further, it is important to assure that the bisulfite conversion process is complete. The strategies described in the Protocols section help address this concern. Finally, once the importance of specific methylation changes is established, the more rapid and technically less demanding methylation specific PCR assays may be used to quickly assess methylation status of the region for high throughput studies (5) . This approach relies on amplifying bisulfite treated DNA with primers specific for sequences that would correspond to bisulfite modified or unmodified dC bases, depending on their methylation status, and determining the relative abundance of both amplified fragments.
Regional or cassette methylation provides valuable supportive evidence for the relevance of methylation changes to gene expression. DNA methylation can suppress gene expression from a distance of up to 500-1000 bp (1), and it is important to determine if methylation changes some distance from a promoter are affecting promoter function. An example is shown in Figure 3B , where methylation of the most 5' sequences of the PRF1 promoter had minimal effect on promoter function, although changes in methylation of this region were detected in 5-azaC treated T cells. Others have reported that strong promoters with only a few CG pairs may also be resistant to suppression by methylation (20) , and cassette methylation may be used to verify the significance of methylation changes in similar situations. The limitations of this approach include the concern that while methylation can promote condensation of intact chromatin, the plasmids used in transient transfections may not necessarily assume the same configuration when methylated.
The relative strengths and weaknesses of 5-azaC as a probe for methylation sensitive genes are well summarized in the literature (16, 21) . 5-azaC has effects on a number of cellular processes including RNA and protein synthesis, while 2-deoxy-5-azaC is more potent and relatively more specific for DNA methylation, but is also more toxic to cells. Both also have a relatively narrow window between concentrations inhibiting DNA methylation and concentrations inhibiting DNA synthesis. Since the treated cells need to go through 2 rounds of cell division before changes in methylation sensitive genes occur (16) , it is often necessary to test a range of concentrations to optimize changes in gene expression. It can also be useful to include treatment with hydroxyurea as control, as this agent will also inhibit DNA synthesis, but does not inhibit DNA methylation (22) . Changes in gene expression similarly affected by 5-azaC and hydroxyurea are likely to be due to DNA synthesis inhibition.
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